Correlation Between LMF Acquisition and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both LMF Acquisition and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LMF Acquisition and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LMF Acquisition Opportunities and Fate Therapeutics, you can compare the effects of market volatilities on LMF Acquisition and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LMF Acquisition with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of LMF Acquisition and Fate Therapeutics.
Diversification Opportunities for LMF Acquisition and Fate Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between LMF and Fate is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding LMF Acquisition Opportunities and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and LMF Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LMF Acquisition Opportunities are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of LMF Acquisition i.e., LMF Acquisition and Fate Therapeutics go up and down completely randomly.
Pair Corralation between LMF Acquisition and Fate Therapeutics
Assuming the 90 days horizon LMF Acquisition Opportunities is expected to generate 1.24 times more return on investment than Fate Therapeutics. However, LMF Acquisition is 1.24 times more volatile than Fate Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.17 per unit of risk. If you would invest 2.72 in LMF Acquisition Opportunities on September 24, 2024 and sell it today you would lose (0.07) from holding LMF Acquisition Opportunities or give up 2.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
LMF Acquisition Opportunities vs. Fate Therapeutics
Performance |
| Timeline |
| LMF Acquisition Oppo |
| Fate Therapeutics |
LMF Acquisition and Fate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with LMF Acquisition and Fate Therapeutics
The main advantage of trading using opposite LMF Acquisition and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LMF Acquisition position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.| LMF Acquisition vs. LMF Acquisition Opportunities | LMF Acquisition vs. Cardio Diagnostics Holdings | LMF Acquisition vs. Revelation Biosciences | LMF Acquisition vs. OmniAb Inc |
| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |